Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Baloxavir-marboxil/nirmatrelvir+ritonavir

Decreased estimated glomerular filtration rate

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yang W, et al. Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series. Infection and Drug Resistance 16 : 4763-4768, Jul 2023. Available from: URL: https://dx.doi.org/10.2147/IDR.S418178 Yang W, et al. Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series. Infection and Drug Resistance 16 : 4763-4768, Jul 2023. Available from: URL: https://dx.doi.org/10.2147/IDR.S418178
Metadaten
Titel
Baloxavir-marboxil/nirmatrelvir+ritonavir
Decreased estimated glomerular filtration rate
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55464-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Dapagliflozin